⚙️
🌟 Najlepsze dopasowanie
Wpisz szukaną frazę, aby zobaczyć propozycje AI.

Targeted import, a life-saving procedure

Targeted import, a life-saving procedure

The only medicine that can help preserve health or life is unavailable – although it is hard to imagine, this is the reality faced by dozens of Polish patients. However, there is a path that allows for importing a medicine into the country that will help, even if it has not been authorized for sale in Poland. We are talking about the targeted import procedure, thanks to which medical products approved in other countries, which cannot be replaced by other preparations available in Poland, reach patients.

For some patients, targeted import is the only mechanism enabling access to therapies with the potential to save health or life.

– says Mateusz Wołkowicz, Business Development Manager for Foreign Markets at Urtica, emphasizing the possibilities offered by the targeted import procedure.

Innovative, for rare diseases, irreplaceable

This special procedure applies to medicines that have no equivalents in Poland, cannot be replaced by other preparations, and are crucial for maintaining the health and life of patients. At the same time, they must not have been subject to proceedings in which the President of the Office for Registration of Medicinal Products refused to grant marketing authorization, refused to renew the authorization, or revoked the marketing authorization.

Usually, within the framework of the targeted import procedure, two main groups of medicinal products can be distinguished in which this mechanism plays a particularly important role. The first consists of innovative oncological drugs, and the second – products used in the treatment of rare diseases. In both cases, the key factor is the fact that they have not yet obtained marketing authorization in the European Union and/or Poland. The targeted import mechanism is the healthcare system’s response to the need to provide patients with the fastest possible access to necessary therapy.

– explains the Urtica expert, who specializes in importing such preparations to Poland.

How to obtain permission?

Obtaining consent for targeted import involves a strictly defined procedure. For a patient to use this path at all, a doctor’s decision is necessary, as it is the doctor who decides on the necessity of using a given medicine and initiates the entire procedure by issuing a request for the import of a specific medicine from outside Poland. Such a request is submitted to the Targeted Import Service System. The final consent for the execution of the request is issued by the Minister of Health.

A positive decision results in the possibility of placing an order with a pharmaceutical wholesaler, and subsequently, the wholesaler acquiring the medicine and importing it into the country.

The effectiveness of acquiring medicines under targeted import depends on many factors, such as broad operational capabilities, an extensive network of business contacts, or excellent knowledge of regulations related to the targeted import procedure, resulting from many years of experience in this area. As part of the support we provide, we provide a comprehensive service – from acquiring the product to its direct delivery to a pharmacy or hospital – so that it reaches the patient in need as quickly as possible. We are aware of how crucial time is in the context of health and life.

– explains Mateusz Wołkowicz from Urtica.

Among the most popular directions from which medicines are imported under the targeted import procedure are the United States, Canada, and Great Britain.

The medicine patients are waiting for

Within the framework of targeted import, it is possible not only to acquire a medicine for a specific patient but also to check a larger batch for a group of patients with the same condition, e.g., for the needs of hospital treatment.

The preparation itself is not reimbursed, but patients can apply for such support on their own. As the Ministry of Health once revealed – it responds positively to about 90% of submitted applications for drug reimbursement. It is also worth being aware that the process of obtaining such reimbursement can take even more than 30 days.

The diseases for which these types of medicines are imported are most often ophthalmological or oncological. The vast majority of medicines are in liquid or powdered form.

Targeted import, a life-saving procedure

Special conditions for a unique medicine

Medicines themselves require unique storage and transport conditions, and innovative ones very often are subject to even stricter restrictions in this regard. Transport from the United States or Japan can be a real challenge, but experience and proper adjustment of procedures at every stage make the venture a success.

The necessity of ensuring a very low temperature, the obligation to monitor the shipment at every stage, time pressure, and the high price of the transported preparation require professionalism and great flexibility throughout the supply chain. Moreover, it is not only intercontinental or international transport that involves a series of procedures. It is also important how the medicine will be stored and transported to the destination in Poland. That is why transport to the hospital/pharmacy is handled by specialized logistics operators providing services for the pharmaceutical market. Only thanks to many years of experience, professional staff, appropriately adapted vehicles, and a well-matched system do all medicines reach patients in optimal time and under the right conditions.

– says Daniel Charucki, Transport Manager at Pharmalink.

Pharmaceutical logistics requires meeting strict legal and quality requirements, resulting both from applicable regulations and the need to ensure the safety of therapy. The continuity of the supply chain, constant monitoring of transport conditions, and precisely defined procedures applicable at every stage of the process are of key importance.

Within the framework of targeted import, close cooperation between various entities responsible for individual stages of the procedure is necessary. An example is the cooperation between Urtica and Pharmalink. Thus, Urtica is responsible for acquiring medicinal products from manufacturers or certified wholesalers and organizing international transport in accordance with applicable standards, while logistics within the country, maintaining the required strict storage and transport conditions, is carried out by Pharmalink. Such an organized process allows for the timely delivery of the medicinal product to the patient while maintaining its quality, effectiveness, and safety.

Source: Pharmalink